Prevention

What Blood Pressure Target in Older Adults with Frailty?

Quick answer

SPRINT (ages ≥75, non-frail) supported a SBP target <120 with reduced CV events and all-cause mortality. In frail or institutionalized older adults, most guidelines settle on SBP 130–140 to balance benefit against falls, AKI, and orthostatic symptoms. Target should be individualized: measure standing BP, screen for frailty, and stop titration when symptomatic hypotension or falls occur.

Evidence review

Pivotal trials, effect sizes, and the populations they studied. PubMed identifiers link directly to the source.

SPRINT (≥75 subgroup) (2016)

PMID 27195814

2,636 adults ≥75 within 9,361 total, non-diabetic, high CV risk

SBP <120 reduced MACE 34% (HR 0.66) and all-cause mortality 33% (HR 0.67) vs <140. Benefit consistent in frail subgroup, but absolute numbers smallest.

STEP (2021)

PMID 34491661

8,511 Chinese adults 60–80

SBP 110–130 target reduced CV events 26% (HR 0.74) vs 130–150. No difference in AKI or syncope.

OPTIMISE (2020)

PMID 32453368

569 frail adults ≥80 with SBP <150

Antihypertensive reduction (by one drug) did not worsen 12-week BP control. Supported deprescribing in frail patients.

Practical decision algorithm

IfThen
Non-frail ≥75, tolerates standing, low fall riskTarget SBP <130 (SPRINT-style).
Mildly frail (CFS 4–5), minor orthostasisTarget SBP 130–140. Measure standing BP at each visit.
Moderate-severe frailty (CFS ≥6), falls, or dementiaTarget SBP 140–150. Consider deprescribing if <130 on current regimen.
Symptomatic orthostasis (drop ≥20/10 with symptoms)Reduce diuretic first, then alpha-blocker or non-dihydropyridine CCB. Avoid clonidine.
SBP <110 on measurementHold or reduce therapy regardless of initial target.

Guideline position

2017 ACC/AHA: SBP target <130 for ≥65 (Class 1). 2024 ESC: <140 in frail; <130 otherwise. AGS Beers 2023: caution at SBP <130 in frail. Expert consensus: individualize; standing BP matters more than target.

Contraindications and cautions

  • Symptomatic orthostatic hypotension (lower target may be unsafe)
  • Recent stroke (acute — permissive hypertension)
  • Severe aortic stenosis (use caution with vasodilators)
  • eGFR <30 — watch for AKI with intensification
  • Recurrent falls on current regimen

Frequently asked questions

Should I use automated office BP or ambulatory?
Automated unattended office BP (as in SPRINT) runs 5–10 mmHg lower than manual. Targets from SPRINT apply to unattended readings. Home BP averaging or 24-h ambulatory is more accurate for frail patients.
How do I assess frailty in a 15-minute visit?
Clinical Frailty Scale (1–9) or FRAIL scale (5 yes/no items): fatigue, resistance, ambulation, illness, loss of weight. 15 seconds to score. Score ≥3 on FRAIL = frail.
Is chlorthalidone still first-line in older adults?
Yes, per ACC/AHA, but HCTZ is equivalent at equipotent doses. Both cause more hyponatremia in elderly. Start at 12.5 mg and titrate. Avoid if sodium <135 or recurrent hyponatremia.
How does SBP target change with dementia?
Evidence is mixed. SPRINT MIND suggested <120 reduced MCI but not dementia. In moderate-severe dementia, prioritize quality of life — SBP 140–150 is usually reasonable.
When to deprescribe antihypertensives?
Frailty onset, orthostatic symptoms, recurrent falls, renal function decline, limited life expectancy. OPTIMISE supports removing one drug at a time with monitoring.

Further reading

Evidence-Based Medicine

Hypertension Management: 2026 ACC/AHA Blood Pressure Targets and Treatment Updates

Clinical Reasoning

Polypharmacy in Elderly Patients: An Evidence-Based Deprescribing Framework

Methodology

Shared Decision-Making with Complex Evidence: A Practical Guide

Back to all decision points